HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Francesc X Avilés Selected Research

human CPA4

3/2005Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Francesc X Avilés Research Topics

Disease

8Neoplasms (Cancer)
03/2013 - 07/2002
2Carcinoma (Carcinomatosis)
03/2013 - 08/2005
2Leukemia
02/2011 - 10/2009
2Prostatic Neoplasms (Prostate Cancer)
06/2007 - 03/2005
1Squamous Cell Carcinoma of Head and Neck
03/2013
1Parasitic Diseases (Parasitic Disease)
10/2009
1Chagas Disease (American Trypanosomiasis)
10/2009
1Acute Promyelocytic Leukemia
10/2009
1Thrombosis (Thrombus)
10/2008
1Acquired Immunodeficiency Syndrome (AIDS)
10/2008
1Neoplasm Metastasis (Metastasis)
09/2008
1Herpes Simplex
09/2008
1Poliomyelitis (Polio)
09/2008
1Proteostasis Deficiencies
09/2003
1Amyloidosis
09/2003
1Alzheimer Disease (Alzheimer's Disease)
07/2002
1Ovarian Neoplasms (Ovarian Cancer)
07/2002
1Parkinson Disease (Parkinson's Disease)
07/2002

Drug/Important Bio-Agent (IBA)

4Cisplatin (Platino)FDA LinkGeneric
02/2011 - 04/2008
2DNA (Deoxyribonucleic Acid)IBA
10/2009 - 11/2005
2Peptide Hydrolases (Proteases)FDA Link
09/2008 - 07/2002
2CarboxypeptidasesIBA
06/2007 - 03/2005
2Proteins (Proteins, Gene)FDA Link
09/2003 - 07/2002
1Biomarkers (Surrogate Marker)IBA
03/2013
1Messenger RNA (mRNA)IBA
03/2013
1NF-kappa B (NF-kB)IBA
03/2013
1phenazineFDA Link
10/2009
1oligomycin sensitivity-conferring protein (complex V)IBA
10/2009
1Intercalating AgentsIBA
10/2009
1LigandsIBA
10/2009
1MetalsIBA
10/2009
1Vanadates (Orthovanadate)IBA
10/2009
1Lysine (L-Lysine)FDA Link
10/2008
1Antifibrinolytic Agents (Antifibrinolytics)IBA
10/2008
1ThrombinFDA Link
10/2008
1FibrinIBA
10/2008
1Cystatin CIBA
09/2008
1CystatinsIBA
09/2008
1Cysteine Proteinase InhibitorsIBA
09/2008
1Cysteine Proteases (Cysteine Protease)IBA
09/2008
1Cathepsin BIBA
09/2008
1Pharmaceutical PreparationsIBA
07/2008
1PlatinumIBA
07/2008
1Biological ProductsIBA
04/2008
1Platinum Compounds (Compounds, Platinum)IBA
04/2008
1Sepharose (Agarose)IBA
11/2005
1ErbB Receptors (EGF Receptor)IBA
08/2005
1Epidermal Growth Factor (EGF)IBA
08/2005
1Transforming Growth Factor alpha (TGF-alpha)IBA
08/2005
1Histone Deacetylase InhibitorsIBA
03/2005
1human CPA4IBA
03/2005
1Peptides (Polypeptides)IBA
09/2003
1Serine Proteases (Serine Protease)IBA
07/2002
1Amyloid (Amyloid Fibrils)IBA
07/2002
1Kallikreins (Kallikrein)IBA
07/2002
1TrypsinIBA
07/2002
1Tumor Biomarkers (Tumor Markers)IBA
07/2002

Therapy/Procedure

1Chemoradiotherapy
03/2013
1Radiotherapy
03/2013
1Therapeutics
08/2005
1Aftercare (After-Treatment)
03/2005